Clopidogrel Acino Euroopa Liit - rumeenia - EMA (European Medicines Agency)

clopidogrel acino

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - agenți antitrombotici - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

LEVOTOR 250 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levotor 250 mg

torrent pharma s.r.l. - levofloxacinum - compr. film. - 250mg - chinolone antibacteriene fluorochinolone

LEVOTOR 500 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levotor 500 mg

torrent pharma s.r.l. - levofloxacinum - compr. film. - 500mg - chinolone antibacteriene fluorochinolone